Procter & Gamble Stock - analyst views and valuation debate

Procter & Gamble remains in focus as analysts and valuation models reassess the consumer staples giant. On this Monday the spotlight is on consensus estimates, rating distribution and how the stock’s rich valuation fits into the current defensive sector backdrop.

Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/22/2026, 07:50 CET. Details in the imprint.

Procter & Gamble (US7427181091) stays a benchmark name in global consumer staples. On this Monday analysts’ valuation models and rating updates put the stock’s premium pricing and consensus expectations under closer scrutiny, according to recent coverage on Procter & Gamble shares.

What recent analyst work shows

External valuation work has highlighted how rich Procter & Gamble’s current stock price looks against some intrinsic value models. A recent Simply Wall St analysis argued the shares might be materially overvalued versus its discounted cash flow estimate of fair value. The Yahoo Finance summary of that analysis points to a more than 20% gap between price and modeled value.

Despite this, the broader analyst community still generally views Procter & Gamble as a high-quality defensive name. Consensus typically skews toward Buy and Hold ratings for the stock, reflecting its strong brands, steady cash flows and reliable dividend profile in the consumer staples sector.

Focus on Monday: consensus and expectations

This Monday’s focus for Procter & Gamble is not a fresh earnings release but the positioning of expectations ahead of the next quarterly report. Investors are watching how consensus sales and earnings estimates for fiscal 2026 evolve in light of sticky inflation and changing consumer behavior.

According to public data platforms that aggregate analyst views, the company is still expected to deliver modest organic sales growth and stable margins over the coming quarters. MarketBeat’s overview of Procter & Gamble shares shows the stock trading near the upper end of its 52-week range, consistent with its perceived resilience in uncertain macro conditions.

How the company makes its money

Procter & Gamble generates its revenue from a broad portfolio of everyday consumer products across beauty, grooming, health care, fabric and home care, and baby, feminine and family care. The group’s brands include Gillette, Oral-B, Ariel, Pampers and many other mass-market household names sold worldwide.

Where the stock trades today

Procter & Gamble shares (US7427181091) trade on the New York Stock Exchange at about $150 per share in recent sessions, with the company valued at roughly $350 billion by market capitalization as of mid-June 2026.

Key facts on Procter & Gamble stock

• Company: The Procter & Gamble Company
• ISIN: US7427181091
• WKN: 852062
• Ticker: PG
• Venue: NYSE
• Price (as of 06/18/2026, 21:58 CET): 150.85 USD
• Market cap: 355,000,000,000 USD (as of 06/18/2026)
• Sector / Industry: Consumer Staples / Household & Personal Products
• Index membership: Dow Jones Industrial Average, S&P 500
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.